DEFENSIN THERAPEUTICS ApS
CVR 35513280 · Private limited company (ApS) · Active · Medium risk
DEFENSIN THERAPEUTICS ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 12 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 774k and a net result of DKK -539k.
Bankruptcy risk for DEFENSIN THERAPEUTICS ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 35513280
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (13 years)
- Address
- c/o Peter Nordkild, Rigensgade 11A, 2.
1316 København K - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 1.4m
- Employees
- 0 (2018)
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 12 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 79.5% |
| Current ratio | 488% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 23 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -539k | – | – |
| Net profit | DKK -539k | DKK -131k | DKK -425k |
| Equity | DKK 774k | DKK 1.3m | DKK 1.4m |
| Total assets | DKK 974k | DKK 1.4m | DKK 1.4m |
| Cash | DKK 888k | DKK 969k | – |
| Short-term debt | DKK 200k | DKK 39k | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 170 | ||
| 1 Jan 2023 – 31 Dec 2023 | 151 | ||
| 1 Jan 2022 – 31 Dec 2022 | 152 | ||
| 1 Jan 2021 – 31 Dec 2021 | 140 | ||
| 1 Jan 2020 – 31 Dec 2020 | 153 | ||
| 1 Jan 2019 – 31 Dec 2019 | 154 | ||
| 1 Jan 2018 – 31 Dec 2018 | 149 | ||
| 1 Jan 2017 – 31 Dec 2017 | 152 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 151 | ||
| 6 Oct 2013 – 31 Dec 2014 | 124 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Peter Hviid Nordkild | Current | |
| Board | Ejner Bech Jensen | Current | |
| Board | Søren Neve | Current | |
| Board | Matthew Alister Cooper | Current | |
| Board | Robert Ehehalt | Current | |
| Board | Jan Wehkamp | ||
| Owner (15%) | NOVOZYMES A/S | Current | |
| Owner (33%) | PN INVESTMENT ApS | Current | |
| Owner (15%) | NEVE INVEST ApS | Current | |
| Owner (15%) | Matthew Allister Cooper | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | JUSMEDICO ADVOKATANPARTSSELSKAB | Current |
Address history (2 moves)
| c/o Peter Nordkild, Rigensgade 11A, 2., 1316 København K | |
| c/o COBIS, Ole Maaløes Vej 3, 2200 København N | |
| c/o PN Investment ApS, Vældegårdsvej 59, 2820 Gentofte |
Employees per year
Other companies at the same address
- ANQOR ApS Bankrupt
- CAPERNOW PROJECTS A/S Bankrupt
- CHBR Holding ApS Bankrupt
- CUB HOLDING ApS Bankrupt
- ESBC HOLDING ApS Bankrupt
- STCH Holding ApS Bankrupt
- STEEN ENGHOLM HOLDING ApS Bankrupt
- STEN Holding ApS Bankrupt
- Selskabet af 7. april 2021 A/S Bankrupt
- Aesculus Bio ApS Active
- Asarina Pharma ApS Opløst
- Balser Holding ApS Active
- Balser Invest ApS Active
- Balser Venture ApS Active
- COMPASS HUMAN RESOURCES GROUP A/S Active
- Clara Bødtcher-Hansen Holding ApS Active
- Climate & Energy Research Institute ApS Active
- Kraka Economics ApS Active
- Next Alliance Group ApS Active
- PN INVESTMENT ApS Active
- People & Performance ApS Active
- RIGENSGADE 11 A/S Opløst
- Sterna Capital Partners Fondsmæglerselskab A/S Active
Similar companies in København
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about DEFENSIN THERAPEUTICS ApS
Has DEFENSIN THERAPEUTICS ApS gone bankrupt?
No, DEFENSIN THERAPEUTICS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of DEFENSIN THERAPEUTICS ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
When was DEFENSIN THERAPEUTICS ApS founded?
DEFENSIN THERAPEUTICS ApS was founded on 6 October 2013.
What is the equity of DEFENSIN THERAPEUTICS ApS?
Equity was DKK 774k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.